| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
119.000 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
119.000 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
119.000 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
119.000 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
119.000 |
Evidence |
|
| LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
119.000 |
Evidence |
|
| LNK |
SH2B3, LNK: SH2B adapter protein 3 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
119.000 |
Evidence |
O
|
| EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
119.000 |
Evidence |
|
| PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
119.000 |
Evidence |
|
| PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
119.000 |
Evidence |
|
| PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
119.000 |
Evidence |
|
| PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
119.000 |
Evidence |
|
| PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
119.000 |
Evidence |
|
| PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
STAT3 |
|
119.000 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
LYN |
LYN: Tyrosine-protein kinase Lyn |
119.000 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
119.000 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
119.000 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
119.000 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
119.000 |
Evidence |
|
| ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
HES6 |
HES6: Transcription cofactor HES-6 |
119.000 |
Evidence |
|
| ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
119.000 |
Evidence |
|
| ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
119.000 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
119.000 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
119.000 |
Evidence |
|
| BID |
BID: BH3-interacting domain death agonist |
BCL2L1 |
BCL2L1, BCL2L, BCLX: Apoptosis regulator Bcl-X |
119.000 |
Evidence |
|